Journal article
A real-world comparison of multi-modality therapies in locally advanced gastro-esophageal junction (GEJ) cancers.
Abstract
96
Background: Trials show that addition of systemic therapy and/or radiation to surgery improves survival in GEJ cancers. However, the different regimens have not been directly compared. We examined population-based outcomes of 3 treatments: 1) neoadjuvant carboplatin and paclitaxel plus radiation (CROSS); 2) perioperative epirubicin, cisplatin, and fluoropyrimidine (MAGIC); and 3) cisplatin and fluoropyrimidine with …
Authors
Samawi H; Tilley D; Tang PA; Spratlin JL; Lee-Ying RM; Cheung WY
Journal
Journal of Clinical Oncology, Vol. 36, No. 4_suppl, pp. 96–96
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2018
DOI
10.1200/jco.2018.36.4_suppl.96
ISSN
0732-183X